Antiplatelet drugs provide first-line antithrombotic therapy for the management of acute ischemic syndromes (both coronary and cerebrovascular) and for the prevention of their recurrence. Their role in the primary prevention of atherothrombosis remains controversial because of the uncertain balance of the potential benefits and risks when combined with other preventive strategies. The aim of this consensus document is to review the evidence for the efficacy and safety of antiplatelet drugs, and to provide practicing cardiologists with an updated instrument to guide their choice of the most appropriate antiplatelet strategy for the individual patient presenting with different clinical manifestations of coronary atherothrombosis, in light of comorbidities and/or interventional procedures.

Patrono, C., Morais, C., Baigent, J., Collet, C., Fitzgerald, J. P., Halvorsen S, D., Rocca, B., Siegbahn,, Storey, A., Vilahur, R. F., G., Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis., <<JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY>>, 2017; 70 (14): 1760-1776. [doi:10.1016/j.jacc.2017.08.037] [http://hdl.handle.net/10807/105783]

Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis.

Patrono, Carlo
Primo
;
Rocca, Bianca;
2017

Abstract

Antiplatelet drugs provide first-line antithrombotic therapy for the management of acute ischemic syndromes (both coronary and cerebrovascular) and for the prevention of their recurrence. Their role in the primary prevention of atherothrombosis remains controversial because of the uncertain balance of the potential benefits and risks when combined with other preventive strategies. The aim of this consensus document is to review the evidence for the efficacy and safety of antiplatelet drugs, and to provide practicing cardiologists with an updated instrument to guide their choice of the most appropriate antiplatelet strategy for the individual patient presenting with different clinical manifestations of coronary atherothrombosis, in light of comorbidities and/or interventional procedures.
2017
Inglese
Patrono, C., Morais, C., Baigent, J., Collet, C., Fitzgerald, J. P., Halvorsen S, D., Rocca, B., Siegbahn,, Storey, A., Vilahur, R. F., G., Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis., <<JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY>>, 2017; 70 (14): 1760-1776. [doi:10.1016/j.jacc.2017.08.037] [http://hdl.handle.net/10807/105783]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/105783
Citazioni
  • ???jsp.display-item.citation.pmc??? 52
  • Scopus 147
  • ???jsp.display-item.citation.isi??? 138
social impact